Pharmacodynamic and pharmacokinetic effects and safety of verinurad in combination with allopurinol in adults with gout: a phase IIa, open-label study

OBJECTIVES: Verinurad (RDEA3170) is a high affinity, selective uric acid transporter (URAT1) inhibitor indevelopment for treating gout and asymptomatic hyperuricaemia. This phase IIa study evaluated the pharmacodynamics, pharmacokinetics and safety of verinurad combined with allopurinol versus allop...

Descripción completa

Detalles Bibliográficos
Autores principales: Fleischmann, Roy, Winkle, Peter, Miner, Jeffrey N, Yan, Xiaohong, Hicks, Liz, Valdez, Shakti, Hall, Jesse, Liu, Sha, Shen, Zancong, Gillen, Michael, Hernandez-Illas, Martha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Crystal Arthropathies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5845419/
https://www.ncbi.nlm.nih.gov/pubmed/29531784
http://dx.doi.org/10.1136/rmdopen-2017-000584

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5845419/
https://www.ncbi.nlm.nih.gov/pubmed/29531784
http://dx.doi.org/10.1136/rmdopen-2017-000584

Ejemplares similares